InSitu Biologics, Inc.
PrivateLast Round
Seed Round
Aug 10, 2026
Est. Valuation
$34M
Total Funding Raised
$10M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
InSitu Biologics, Inc. is a biotechnology company that develops a multi-phase prolonged-release drug delivery platform for the localized treatment of pain, cancer, and infection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InSitu Biologics, Inc. Comparables
Compare InSitu Biologics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Concentric Analgesics | 84% | |
| Sustained Therapeutics | 84% | |
| AmacaThera | 83% | |
InSitu Biologics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 10, 2026 | ||||
| Series A | Dec 28, 2021 | ||||
| Corporate Funding | Jul 31, 2018 |
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 10, 2026
$1.25M seed round completed.
- Jul 24, 2026
Monthly visitors increased 59% MoM.
InSitu Biologics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about InSitu Biologics, Inc.'s valuation, stock price, and market status.